Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Min Sang | - |
dc.contributor.author | Lee, Jung Eun | - |
dc.contributor.author | Byun, Eunkyoung | - |
dc.contributor.author | Kim, Nak Won | - |
dc.contributor.author | Lee, Kyuri | - |
dc.contributor.author | Lee, Haeshin | - |
dc.contributor.author | Sim, Sang Jun | - |
dc.contributor.author | Lee, Doo Sung | - |
dc.contributor.author | Jeong, Ji Hoon | - |
dc.date.accessioned | 2021-09-05T03:53:12Z | - |
dc.date.available | 2021-09-05T03:53:12Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-10-28 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97050 | - |
dc.description.abstract | Low cytotoxicity and high cellular gene delivery capability are among the most important prerequisites for the selection of a non-viral carrier. Although calciumphosphate (CAP) nanoparticles have been long used for animal cell transfection, its rapid and uncontrollable crystal growth and lack of tissue specificity are among the most challenging problems that limit its use in the clinic. In this study, we report the development of CAP nanoparticles stabilized by a conjugate of the mussel-inspired adhesive molecule, 3,4-dihydroxy-L-phenylalanine (dopa), and a nontoxic hydrophilic natural polymer, hyaluronic acid (HA), for targeted siRNA delivery to tumors. CAP/siRNA/dopa-HA can form compact nanoparticles that effectively protect siRNA from enzymatic degradation despite the structural drawbacks of siRNA, such as low charge density and short and rigid structure. In addition, stabilized CAP nanoparticles were able to maintain their colloidal stability in a physiological salt condition for over a week. The superior ability of CAP/siRNA/dopa-HA to maintain the integrity of encapsulated siRNA and the stability in solution of the nanoparticles allow this formulation to achieve improved intratumoral accumulation of siRNA and a high level of target gene silencing in solid tumors after systemic administration. Considering its biocompatibility, transfection efficacy, and tumor targeting capability, this stabilized calciumphosphate nanoparticle-based gene delivery platform should be considered a promising candidate carrier for systemic siRNA delivery and targeted cancer therapy. (C) 2014 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER | - |
dc.subject | INTRACELLULAR DELIVERY | - |
dc.subject | CD44 | - |
dc.subject | ENVIRONMENT | - |
dc.subject | RECEPTOR | - |
dc.subject | BINDING | - |
dc.subject | CARRIER | - |
dc.title | Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sim, Sang Jun | - |
dc.identifier.doi | 10.1016/j.jconrel.2014.06.049 | - |
dc.identifier.scopusid | 2-s2.0-84905061755 | - |
dc.identifier.wosid | 000342460400013 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CONTROLLED RELEASE, v.192, pp.122 - 130 | - |
dc.relation.isPartOf | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.title | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.volume | 192 | - |
dc.citation.startPage | 122 | - |
dc.citation.endPage | 130 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | INTRACELLULAR DELIVERY | - |
dc.subject.keywordPlus | CD44 | - |
dc.subject.keywordPlus | ENVIRONMENT | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | BINDING | - |
dc.subject.keywordPlus | CARRIER | - |
dc.subject.keywordAuthor | Gene delivery | - |
dc.subject.keywordAuthor | Calcium phosphate nanoparticle | - |
dc.subject.keywordAuthor | Targeted delivery | - |
dc.subject.keywordAuthor | 3,4-Dihydroxy-L-phenylalanine | - |
dc.subject.keywordAuthor | Hyaluronic acid | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.